Hypera S.A. HYPMY

HYPMY Company Overview

Hypera S.A. is a Brazil-based pharmaceutical and consumer health company engaged in the development, manufacturing, marketing, and distribution of prescription medicines, over-the-counter (OTC) products, generics, branded generics, vitamins, dermatological products, and health-related consumer goods. The company operates primarily in the pharmaceutical and consumer healthcare industries and is one of the largest pharmaceutical companies in Brazil by market presence and brand portfolio. Its revenue is primarily driven by branded prescription drugs, OTC medicines, and established consumer health brands sold through pharmacies, distributors, hospitals, and retail chains.

The company traces its origins to Prática Laboratórios and later evolved through a series of mergers, restructurings, and acquisitions before adopting the Hypera identity. Hypera expanded significantly through acquisitions of established pharmaceutical portfolios and consumer health assets in Brazil, including products acquired from multinational pharmaceutical companies divesting non-core brands. Its strategic positioning is supported by strong brand recognition in the Brazilian healthcare market, extensive domestic distribution capabilities, and a diversified portfolio across therapeutic categories including pain relief, digestive health, dermatology, respiratory care, and vitamins.